U.S. markets close in 41 minutes
  • S&P 500

    3,631.33
    -4.08 (-0.11%)
     
  • Dow 30

    29,882.37
    -163.87 (-0.55%)
     
  • Nasdaq

    12,100.88
    +64.09 (+0.53%)
     
  • Russell 2000

    1,848.11
    -5.42 (-0.29%)
     
  • Crude Oil

    45.61
    +0.70 (+1.56%)
     
  • Gold

    1,806.30
    +1.70 (+0.09%)
     
  • Silver

    23.38
    +0.08 (+0.34%)
     
  • EUR/USD

    1.1926
    +0.0030 (+0.25%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • GBP/USD

    1.3389
    +0.0030 (+0.23%)
     
  • USD/JPY

    104.4160
    -0.0640 (-0.06%)
     
  • BTC-USD

    18,856.88
    -183.95 (-0.97%)
     
  • CMC Crypto 200

    373.24
    +2.73 (+0.74%)
     
  • FTSE 100

    6,391.09
    -41.08 (-0.64%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Prothena: 4Q Earnings Snapshot

DUN LAOGHAIRE, Ireland (AP) _ Prothena Corp. (PRTA) on Thursday reported a loss of $22.5 million in its fourth quarter.

The Dun Laoghaire, Ireland-based company said it had a loss of 56 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 96 cents per share.

The drug developer posted revenue of $194,000 in the period.

For the year, the company reported that its loss widened to $155.6 million, or $3.93 per share. Revenue was reported as $955,000.

Prothena shares have risen 24 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $12.75, a drop of 59 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTA at https://www.zacks.com/ap/PRTA